龙津药业(002750) - 2017年5月15日投资者关系活动记录表

Group 1: Company Overview and Investment Strategy - The company aims to expand its scale through mergers and acquisitions, primarily focusing on the pharmaceutical industry for suitable targets [2] - Future prescription drug markets are expected to remain constrained, prompting the company to consider development in OTC and health sectors, including prevention and rehabilitation [2] - The company seeks to invest in advantageous products or acquire equity stakes in companies with high net profit margins [2] Group 2: Financial Management - Idle funds are mainly used for purchasing bank principal-protected financial products, with financing needs dependent on the availability of investment projects and their actual funding requirements [2] Group 3: Marketing Strategy - The current sales model combines agents with refined marketing, with essential drug provinces like Shandong, Henan, and Yunnan contributing approximately 30% to sales [3] - Each provincial area has a market manager supported by 1-2 academic specialists, and the company plans to expand its marketing team by learning from successful practices of other companies [3]